What is a tumor board and should my Small Bowel Cancer case be reviewed by one
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Tumor Boards and Small Bowel Cancer
What Is a Tumor Board?
A tumor board (also called a multidisciplinary tumor conference or cancer conference) is a meeting where a team of cancer specialists from different fields reviews individual patient cases together. Think of it as a "second opinion by committee."
Who typically participates:
- Medical oncologists (chemotherapy specialists)
- Surgical oncologists (cancer surgeons)
- Radiation oncologists (radiation therapy specialists)
- Pathologists (specialists who examine tissue samples)
- Radiologists (imaging specialists)
- Gastroenterologists or other relevant specialists
- Nurses and other support staff
What they do: The team reviews your [ID removed] imaging scans, pathology reports, and lab results together. They discuss your specific situation and recommend the best treatment approach based on current evidence and their combined expertise.
Should Your Small Bowel Cancer Case Be Reviewed?
Yes—strongly consider requesting a tumor board review. Here's why:
Small Bowel Cancer Is Complex and Rare
According to the NCCN Guidelines for Small Bowel Adenocarcinoma (Version 4.2025), small bowel cancer has a distinct genetic profile that sets it apart from more common cancers like colorectal cancer. The guidelines specifically note that:
- Small bowel cancers have different mutation patterns than colorectal cancer (for example, APC mutations are much less common in small bowel cancer)
- HER2 alterations, MSI-H/dMMR status, and tumor mutational burden (TMB-H) are more common in small bowel cancer compared to colorectal cancer
- Treatment decisions depend heavily on these specific genetic features
Because small bowel cancer is rare and requires personalized genetic testing to guide treatment, a multidisciplinary team review is especially valuable.
NCCN Recommends Multidisciplinary Evaluation
The NCCN Guidelines emphasize that "patients should be evaluated by multidisciplinary teams at high-volume centers" when considering complex treatment decisions, particularly for:
- Radiation therapy planning
- Surgical cases with positive margins
- Advanced disease requiring systemic therapy decisions
Key Questions to Ask Your Oncology Team
- Has my case been reviewed by a tumor board, or can it be?
- What genetic testing has been done on my tumor? (This is critical for small bowel cancer treatment planning)
- If my case hasn't been reviewed yet, can you submit it to your institution's tumor board?
- Should I seek a second opinion at a high-volume cancer center that specializes in small bowel cancer?
- What specific biomarkers have been tested? (Ask about MSI/dMMR status, TMB, HER2, BRAF, NTRK, and RET mutations—these guide treatment options)
Why This Matters for Your Treatment
According to NCCN Guidelines, treatment recommendations for small bowel cancer depend on:
- Whether your tumor has specific genetic mutations (which determine if you're eligible for targeted therapies)
- Your disease stage (localized vs. advanced/metastatic)
- Your overall health and ability to tolerate intensive therapy
- Prior treatments you've received
A tumor board can help ensure your care team considers all available options specific to YOUR tumor's characteristics.
Finding a Tumor Board
- Ask your oncologist if your case can be presented at their institution's tumor board
- Contact major cancer centers (academic medical centers, NCI-designated cancer centers) that treat small bowel cancer
- Consider seeking care at a high-volume center if your current facility has limited small bowel cancer experience
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: